Table 1.
Spectral domain optic coherence tomography (SD–OCT) imaging and Humphrey field analyzer (HFA) evaluation of early–stage AMD patients.
| Pt ID | Age (years) | Eye | VAa | SD–OCT
|
HFA | ||||
|---|---|---|---|---|---|---|---|---|---|
| decrease in retinal thickness | ONL disruption with retinal folds | ||||||||
| fovea | para– or peri–fovea | fovea | para– or peri–fovea | MD (dB) | PSD (dB) | ||||
| 1 | 83 | OD | 20/20 | + | − | − | Not clear | N.A. | N.A. |
| 2 | 67 | OD | 20/20 | − | + | − | + | 0.12 | 1.79 |
| OS | 20/20 | − | + | − | + | 0.3 | 1.35 | ||
| 3 | 72 | OD | 20/20 | + | + | − | + | −3.16 (P<2%) | 1.70 (P<5%) |
| 4 | 75 | OD | N.A. | − | + | − | + | N.A. | N.A. |
| OS | N.A. | − | − | − | + | N.A. | N.A. | ||
| 5 | 79 | OS | 20/20 | − | − | − | + | −0.34 | 1.73 |
| 6 | 83 | OD | N.A. | − | − | − | + | N.A. | N.A. |
| OS | N.A. | − | + | − | + | N.A. | N.A. | ||
|
| |||||||||
| Pathological changes in OCT | 2/9 (22%) | 5/9 (56%) | 0/0 (0%) | 8/9 (89%) | |||||
a
VA, visual acuity; MD, mean deviation; PSD, pattern standard deviation; N.A., not available; ONL, outer nuclear layer; dB, decibel.